Pridinol (mesylate)

Pridinol mesylate is an orally active, blood-brain permeable, muscarinic acetylcholine receptor (mAChR) -directed muscle relaxant. Pridinol mesylate reduces the conduction of impulses to spinal motor neurons and exerts muscle relaxant activity. Pridinol mesylate inhibits skeletal muscle contractures in diseases of both central and peripheral origin and can be used in research in the field of musculoskeletal diseases[1][2].

Product Specifications

CAS Number

[6856-31-1]

UNSPSC

12352005

Hazard Statement

H302+H312+H332

Target

Cholinesterase (ChE)

Type

Reference compound

Related Pathways

Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/pridinol-mesylate.html

Purity

99.97

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

CS(=O)(O)=O.OC(C1=CC=CC=C1)(C2=CC=CC=C2)CCN3CCCCC3

Molecular Formula

C21H29NO4S

Molecular Weight

391.52

Precautions

H302+H312+H332

References & Citations

[1]Richter M, et al. Pharmacokinetics of oral pridinol: Results of a randomized, crossover bioequivalence trial in healthy subjects. Int J Clin Pharmacol Ther. 2021 Jun;59 (6) :471-477.|[2]Lauricella L, et al. Effectiveness rehabilitative therapy and Pridinol Mesylate in low back pain. Front Med (Lausanne) . 2025 Jan 22;11:1470996.